author_facet Farfalli, Germán L.
Albergo, Jose I.
Piuzzi, Nicolas S.
Ayerza, Miguel A.
Muscolo, D. Luis
Ritacco, Lucas E.
Aponte-Tinao, Luis A.
Farfalli, Germán L.
Albergo, Jose I.
Piuzzi, Nicolas S.
Ayerza, Miguel A.
Muscolo, D. Luis
Ritacco, Lucas E.
Aponte-Tinao, Luis A.
author Farfalli, Germán L.
Albergo, Jose I.
Piuzzi, Nicolas S.
Ayerza, Miguel A.
Muscolo, D. Luis
Ritacco, Lucas E.
Aponte-Tinao, Luis A.
spellingShingle Farfalli, Germán L.
Albergo, Jose I.
Piuzzi, Nicolas S.
Ayerza, Miguel A.
Muscolo, D. Luis
Ritacco, Lucas E.
Aponte-Tinao, Luis A.
Clinical Orthopaedics & Related Research
Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors?
Orthopedics and Sports Medicine
General Medicine
Surgery
author_sort farfalli, germán l.
spelling Farfalli, Germán L. Albergo, Jose I. Piuzzi, Nicolas S. Ayerza, Miguel A. Muscolo, D. Luis Ritacco, Lucas E. Aponte-Tinao, Luis A. 0009-921X Ovid Technologies (Wolters Kluwer Health) Orthopedics and Sports Medicine General Medicine Surgery http://dx.doi.org/10.1007/s11999.0000000000000054 <jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background</jats:title> <jats:p>The treatment of locally aggressive bone tumors is a balance between achieving local tumor control and surgical morbidity. Wide resection decreases the likelihood of local recurrence, although wide resection may result in more complications than would happen after curettage. Navigation-assisted surgery may allow more precise resection, perhaps making it possible to expand the procedure’s indications and decrease the likelihood of recurrence; however, to our knowledge, comparative studies have not been performed.</jats:p> </jats:sec> <jats:sec> <jats:title>Questions/purposes</jats:title> <jats:p>The purpose of this study was to compare curettage plus phenol as a local adjuvant with navigation-guided en bloc resection in terms of (1) local recurrence; (2) nononcologic complications; and (3) function as measured by revised Musculoskeletal Tumor Society (MSTS) scores.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>Patients with a metaphyseal and/or epiphyseal locally aggressive primary bone tumor treated by curettage and adjuvant therapy or en bloc resection assisted by navigation between 2010 and 2014 were considered for this retrospective study. Patients with a histologic diagnosis of a primary aggressive benign bone tumor or low-grade chondrosarcoma were included. During this time period, we treated 45 patients with curettage of whom 43 (95%) were available for followup at a minimum of 24 months (mean, 37 months; range, 24-61 months), and we treated 26 patients with navigation-guided en bloc resection, of whom all (100%) were available for study. During this period, we generally performed curettage with phenol when the lesion was in contact with subchondral bone. We treated tumors that were at least 5 mm from the subchondral bone, such that en bloc resection was considered possible with computer-assisted block resection. There were no differences in terms of age, gender, tumor type, or tumor location between the groups. Outcomes, including allograft healing, nonunion, tumor recurrence, fracture, hardware failure, infection, and revised MSTS score, were recorded. Bone consolidation was defined as complete periosteal and endosteal bridging visible between the allograft-host junctions in at least two different radiographic views and the absence of pain and instability in the union site. All study data were obtained from our longitudinally maintained oncology database.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>In the curettage group, two patients developed a local recurrence, and no local recurrences were recorded in patients treated with en bloc resection. All patients who underwent navigation-guided resection achieved tumor-free margins. Intraoperative navigation was performed successfully in all patients and there were no failures in registration. Postoperative complications did not differ between the groups: in patients undergoing curettage, 7% (three of 43) and in patients undergoing navigation, 4% (one of 26) had a complication. There was no difference in functional scores: mean MSTS score for patients undergoing curettage was 28 points (range, 27–30 points) and for patients undergoing navigation, 29 (range, 27-30 points; p = 0.10).</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>In this small comparative series, navigation-assisted resection techniques allowed conservative en bloc resection of locally aggressive primary bone tumors with no local recurrence. Nevertheless, with the numbers available, we saw no difference between the groups in terms of local recurrence risk, complications, or function. Until or unless studies demonstrate an advantage to navigation-guided en bloc resection, we cannot recommend wide use of this novel technique because it adds surgical time and expense.</jats:p> </jats:sec> <jats:sec> <jats:title>Level of Evidence</jats:title> <jats:p>Level III, therapeutic study.</jats:p> </jats:sec> Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors? Clinical Orthopaedics & Related Research
doi_str_mv 10.1007/s11999.0000000000000054
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwNy9zMTE5OTkuMDAwMDAwMDAwMDAwMDA1NA
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwNy9zMTE5OTkuMDAwMDAwMDAwMDAwMDA1NA
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
imprint Ovid Technologies (Wolters Kluwer Health), 2018
imprint_str_mv Ovid Technologies (Wolters Kluwer Health), 2018
issn 0009-921X
issn_str_mv 0009-921X
language English
mega_collection Ovid Technologies (Wolters Kluwer Health) (CrossRef)
match_str farfalli2018isnavigationguidedenblocresectionadvantageouscomparedwithintralesionalcurettageforlocallyaggressivebonetumors
publishDateSort 2018
publisher Ovid Technologies (Wolters Kluwer Health)
recordtype ai
record_format ai
series Clinical Orthopaedics & Related Research
source_id 49
title Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors?
title_unstemmed Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors?
title_full Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors?
title_fullStr Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors?
title_full_unstemmed Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors?
title_short Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors?
title_sort is navigation-guided en bloc resection advantageous compared with intralesional curettage for locally aggressive bone tumors?
topic Orthopedics and Sports Medicine
General Medicine
Surgery
url http://dx.doi.org/10.1007/s11999.0000000000000054
publishDate 2018
physical 511-517
description <jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background</jats:title> <jats:p>The treatment of locally aggressive bone tumors is a balance between achieving local tumor control and surgical morbidity. Wide resection decreases the likelihood of local recurrence, although wide resection may result in more complications than would happen after curettage. Navigation-assisted surgery may allow more precise resection, perhaps making it possible to expand the procedure’s indications and decrease the likelihood of recurrence; however, to our knowledge, comparative studies have not been performed.</jats:p> </jats:sec> <jats:sec> <jats:title>Questions/purposes</jats:title> <jats:p>The purpose of this study was to compare curettage plus phenol as a local adjuvant with navigation-guided en bloc resection in terms of (1) local recurrence; (2) nononcologic complications; and (3) function as measured by revised Musculoskeletal Tumor Society (MSTS) scores.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>Patients with a metaphyseal and/or epiphyseal locally aggressive primary bone tumor treated by curettage and adjuvant therapy or en bloc resection assisted by navigation between 2010 and 2014 were considered for this retrospective study. Patients with a histologic diagnosis of a primary aggressive benign bone tumor or low-grade chondrosarcoma were included. During this time period, we treated 45 patients with curettage of whom 43 (95%) were available for followup at a minimum of 24 months (mean, 37 months; range, 24-61 months), and we treated 26 patients with navigation-guided en bloc resection, of whom all (100%) were available for study. During this period, we generally performed curettage with phenol when the lesion was in contact with subchondral bone. We treated tumors that were at least 5 mm from the subchondral bone, such that en bloc resection was considered possible with computer-assisted block resection. There were no differences in terms of age, gender, tumor type, or tumor location between the groups. Outcomes, including allograft healing, nonunion, tumor recurrence, fracture, hardware failure, infection, and revised MSTS score, were recorded. Bone consolidation was defined as complete periosteal and endosteal bridging visible between the allograft-host junctions in at least two different radiographic views and the absence of pain and instability in the union site. All study data were obtained from our longitudinally maintained oncology database.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>In the curettage group, two patients developed a local recurrence, and no local recurrences were recorded in patients treated with en bloc resection. All patients who underwent navigation-guided resection achieved tumor-free margins. Intraoperative navigation was performed successfully in all patients and there were no failures in registration. Postoperative complications did not differ between the groups: in patients undergoing curettage, 7% (three of 43) and in patients undergoing navigation, 4% (one of 26) had a complication. There was no difference in functional scores: mean MSTS score for patients undergoing curettage was 28 points (range, 27–30 points) and for patients undergoing navigation, 29 (range, 27-30 points; p = 0.10).</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>In this small comparative series, navigation-assisted resection techniques allowed conservative en bloc resection of locally aggressive primary bone tumors with no local recurrence. Nevertheless, with the numbers available, we saw no difference between the groups in terms of local recurrence risk, complications, or function. Until or unless studies demonstrate an advantage to navigation-guided en bloc resection, we cannot recommend wide use of this novel technique because it adds surgical time and expense.</jats:p> </jats:sec> <jats:sec> <jats:title>Level of Evidence</jats:title> <jats:p>Level III, therapeutic study.</jats:p> </jats:sec>
container_issue 3
container_start_page 511
container_title Clinical Orthopaedics & Related Research
container_volume 476
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792335833828687873
geogr_code not assigned
last_indexed 2024-03-01T14:50:50.77Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Is+Navigation-guided+En+Bloc+Resection+Advantageous+Compared+With+Intralesional+Curettage+for+Locally+Aggressive+Bone+Tumors%3F&rft.date=2018-03-01&genre=article&issn=0009-921X&volume=476&issue=3&spage=511&epage=517&pages=511-517&jtitle=Clinical+Orthopaedics+%26+Related+Research&atitle=Is+Navigation-guided+En+Bloc+Resection+Advantageous+Compared+With+Intralesional+Curettage+for+Locally+Aggressive+Bone+Tumors%3F&aulast=Aponte-Tinao&aufirst=Luis+A.&rft_id=info%3Adoi%2F10.1007%2Fs11999.0000000000000054&rft.language%5B0%5D=eng
SOLR
_version_ 1792335833828687873
author Farfalli, Germán L., Albergo, Jose I., Piuzzi, Nicolas S., Ayerza, Miguel A., Muscolo, D. Luis, Ritacco, Lucas E., Aponte-Tinao, Luis A.
author_facet Farfalli, Germán L., Albergo, Jose I., Piuzzi, Nicolas S., Ayerza, Miguel A., Muscolo, D. Luis, Ritacco, Lucas E., Aponte-Tinao, Luis A., Farfalli, Germán L., Albergo, Jose I., Piuzzi, Nicolas S., Ayerza, Miguel A., Muscolo, D. Luis, Ritacco, Lucas E., Aponte-Tinao, Luis A.
author_sort farfalli, germán l.
container_issue 3
container_start_page 511
container_title Clinical Orthopaedics & Related Research
container_volume 476
description <jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background</jats:title> <jats:p>The treatment of locally aggressive bone tumors is a balance between achieving local tumor control and surgical morbidity. Wide resection decreases the likelihood of local recurrence, although wide resection may result in more complications than would happen after curettage. Navigation-assisted surgery may allow more precise resection, perhaps making it possible to expand the procedure’s indications and decrease the likelihood of recurrence; however, to our knowledge, comparative studies have not been performed.</jats:p> </jats:sec> <jats:sec> <jats:title>Questions/purposes</jats:title> <jats:p>The purpose of this study was to compare curettage plus phenol as a local adjuvant with navigation-guided en bloc resection in terms of (1) local recurrence; (2) nononcologic complications; and (3) function as measured by revised Musculoskeletal Tumor Society (MSTS) scores.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>Patients with a metaphyseal and/or epiphyseal locally aggressive primary bone tumor treated by curettage and adjuvant therapy or en bloc resection assisted by navigation between 2010 and 2014 were considered for this retrospective study. Patients with a histologic diagnosis of a primary aggressive benign bone tumor or low-grade chondrosarcoma were included. During this time period, we treated 45 patients with curettage of whom 43 (95%) were available for followup at a minimum of 24 months (mean, 37 months; range, 24-61 months), and we treated 26 patients with navigation-guided en bloc resection, of whom all (100%) were available for study. During this period, we generally performed curettage with phenol when the lesion was in contact with subchondral bone. We treated tumors that were at least 5 mm from the subchondral bone, such that en bloc resection was considered possible with computer-assisted block resection. There were no differences in terms of age, gender, tumor type, or tumor location between the groups. Outcomes, including allograft healing, nonunion, tumor recurrence, fracture, hardware failure, infection, and revised MSTS score, were recorded. Bone consolidation was defined as complete periosteal and endosteal bridging visible between the allograft-host junctions in at least two different radiographic views and the absence of pain and instability in the union site. All study data were obtained from our longitudinally maintained oncology database.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>In the curettage group, two patients developed a local recurrence, and no local recurrences were recorded in patients treated with en bloc resection. All patients who underwent navigation-guided resection achieved tumor-free margins. Intraoperative navigation was performed successfully in all patients and there were no failures in registration. Postoperative complications did not differ between the groups: in patients undergoing curettage, 7% (three of 43) and in patients undergoing navigation, 4% (one of 26) had a complication. There was no difference in functional scores: mean MSTS score for patients undergoing curettage was 28 points (range, 27–30 points) and for patients undergoing navigation, 29 (range, 27-30 points; p = 0.10).</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>In this small comparative series, navigation-assisted resection techniques allowed conservative en bloc resection of locally aggressive primary bone tumors with no local recurrence. Nevertheless, with the numbers available, we saw no difference between the groups in terms of local recurrence risk, complications, or function. Until or unless studies demonstrate an advantage to navigation-guided en bloc resection, we cannot recommend wide use of this novel technique because it adds surgical time and expense.</jats:p> </jats:sec> <jats:sec> <jats:title>Level of Evidence</jats:title> <jats:p>Level III, therapeutic study.</jats:p> </jats:sec>
doi_str_mv 10.1007/s11999.0000000000000054
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwNy9zMTE5OTkuMDAwMDAwMDAwMDAwMDA1NA
imprint Ovid Technologies (Wolters Kluwer Health), 2018
imprint_str_mv Ovid Technologies (Wolters Kluwer Health), 2018
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229
issn 0009-921X
issn_str_mv 0009-921X
language English
last_indexed 2024-03-01T14:50:50.77Z
match_str farfalli2018isnavigationguidedenblocresectionadvantageouscomparedwithintralesionalcurettageforlocallyaggressivebonetumors
mega_collection Ovid Technologies (Wolters Kluwer Health) (CrossRef)
physical 511-517
publishDate 2018
publishDateSort 2018
publisher Ovid Technologies (Wolters Kluwer Health)
record_format ai
recordtype ai
series Clinical Orthopaedics & Related Research
source_id 49
spelling Farfalli, Germán L. Albergo, Jose I. Piuzzi, Nicolas S. Ayerza, Miguel A. Muscolo, D. Luis Ritacco, Lucas E. Aponte-Tinao, Luis A. 0009-921X Ovid Technologies (Wolters Kluwer Health) Orthopedics and Sports Medicine General Medicine Surgery http://dx.doi.org/10.1007/s11999.0000000000000054 <jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background</jats:title> <jats:p>The treatment of locally aggressive bone tumors is a balance between achieving local tumor control and surgical morbidity. Wide resection decreases the likelihood of local recurrence, although wide resection may result in more complications than would happen after curettage. Navigation-assisted surgery may allow more precise resection, perhaps making it possible to expand the procedure’s indications and decrease the likelihood of recurrence; however, to our knowledge, comparative studies have not been performed.</jats:p> </jats:sec> <jats:sec> <jats:title>Questions/purposes</jats:title> <jats:p>The purpose of this study was to compare curettage plus phenol as a local adjuvant with navigation-guided en bloc resection in terms of (1) local recurrence; (2) nononcologic complications; and (3) function as measured by revised Musculoskeletal Tumor Society (MSTS) scores.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>Patients with a metaphyseal and/or epiphyseal locally aggressive primary bone tumor treated by curettage and adjuvant therapy or en bloc resection assisted by navigation between 2010 and 2014 were considered for this retrospective study. Patients with a histologic diagnosis of a primary aggressive benign bone tumor or low-grade chondrosarcoma were included. During this time period, we treated 45 patients with curettage of whom 43 (95%) were available for followup at a minimum of 24 months (mean, 37 months; range, 24-61 months), and we treated 26 patients with navigation-guided en bloc resection, of whom all (100%) were available for study. During this period, we generally performed curettage with phenol when the lesion was in contact with subchondral bone. We treated tumors that were at least 5 mm from the subchondral bone, such that en bloc resection was considered possible with computer-assisted block resection. There were no differences in terms of age, gender, tumor type, or tumor location between the groups. Outcomes, including allograft healing, nonunion, tumor recurrence, fracture, hardware failure, infection, and revised MSTS score, were recorded. Bone consolidation was defined as complete periosteal and endosteal bridging visible between the allograft-host junctions in at least two different radiographic views and the absence of pain and instability in the union site. All study data were obtained from our longitudinally maintained oncology database.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>In the curettage group, two patients developed a local recurrence, and no local recurrences were recorded in patients treated with en bloc resection. All patients who underwent navigation-guided resection achieved tumor-free margins. Intraoperative navigation was performed successfully in all patients and there were no failures in registration. Postoperative complications did not differ between the groups: in patients undergoing curettage, 7% (three of 43) and in patients undergoing navigation, 4% (one of 26) had a complication. There was no difference in functional scores: mean MSTS score for patients undergoing curettage was 28 points (range, 27–30 points) and for patients undergoing navigation, 29 (range, 27-30 points; p = 0.10).</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>In this small comparative series, navigation-assisted resection techniques allowed conservative en bloc resection of locally aggressive primary bone tumors with no local recurrence. Nevertheless, with the numbers available, we saw no difference between the groups in terms of local recurrence risk, complications, or function. Until or unless studies demonstrate an advantage to navigation-guided en bloc resection, we cannot recommend wide use of this novel technique because it adds surgical time and expense.</jats:p> </jats:sec> <jats:sec> <jats:title>Level of Evidence</jats:title> <jats:p>Level III, therapeutic study.</jats:p> </jats:sec> Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors? Clinical Orthopaedics & Related Research
spellingShingle Farfalli, Germán L., Albergo, Jose I., Piuzzi, Nicolas S., Ayerza, Miguel A., Muscolo, D. Luis, Ritacco, Lucas E., Aponte-Tinao, Luis A., Clinical Orthopaedics & Related Research, Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors?, Orthopedics and Sports Medicine, General Medicine, Surgery
title Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors?
title_full Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors?
title_fullStr Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors?
title_full_unstemmed Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors?
title_short Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors?
title_sort is navigation-guided en bloc resection advantageous compared with intralesional curettage for locally aggressive bone tumors?
title_unstemmed Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors?
topic Orthopedics and Sports Medicine, General Medicine, Surgery
url http://dx.doi.org/10.1007/s11999.0000000000000054